HHealthcare Read More Danaher to buy Masimo in $9.9 billion deal in diagnostics pushFebruary 17, 2026 The Masimo logo is displayed at Masimo headquarters on December 27, 2023 in Irvine, California. Mario Tama |…
MMental health Read More Nevada hit with $447K fine for continued delays in mental health care for defendantsFebruary 11, 2026 Nevada will pay $447,000 in court-ordered fines for continued delays in providing mental health care to criminal defendants…
HHealthcare Read More CVS Health (CVS) earnings Q4 2025February 10, 2026 A pedestrian walks by a CVS store in Greenbrae, California, on July 31, 2025. Justin Sullivan | Getty…
HHealthcare Read More Pfizer execs talk Metsera obesity drugFebruary 6, 2026 Albert Bourla, chairman and CEO of Pfizer, speaks at The Wall Street Journal’s Future of Everything Festival in…
HHealthcare Read More Eli Lilly CEO David Ricks talks Medicare coverage of obesity pillsJanuary 31, 2026 Eli Lilly CEO Dave Ricks on Friday said upcoming Medicare coverage of obesity drugs could be a major…
HHealthcare Read More Eli Lilly plans $3.5 billion Pennsylvania plant for obesity drugsJanuary 30, 2026 Eli Lilly Chair and CEO Dave Ricks speaks during a press conference in Houston, Sept. 23, 2025. Antranik…
HHealthcare Read More 15 drugs added to Medicare price negotiationsJanuary 28, 2026 Boxes of the drug trulicity, made by Eli Lilly and Company, sit on a counter at a pharmacy…
HHealthcare Read More UnitedHealth Group (UNH) earnings Q4 2025January 27, 2026 UnitedHealth Group Inc. signage on the floor of the New York Stock Exchange (NYSE) in New York, US,…
HHealthcare Read More Another alliance of health care and AI signals why pharma stocks could be backJanuary 21, 2026 Bristol Myers Squibb and Microsoft ‘s new partnership aimed at accelerating early detection of lung cancer marks the…
HHealthcare Read More Novo Nordisk shares rise after Wegovy obesity pill launchJanuary 16, 2026 A pharmacist displays a box of Wegovy pills at a pharmacy in Provo, Utah, US, on Thursday, Jan.…
HHealthcare Read More Johnson & Johnson halts mid-stage trial of experimental eczema drugDecember 26, 2025 Johnson & Johnson offices in Irvine, California, US, on Friday, Oct. 10, 2025. Kyle Grillot | Bloomberg |…
HHealthcare Read More Eli Lilly investors shouldn’t sweat rival Novo Nordisk having the first obesity pill on saleDecember 25, 2025 Jim Cramer says don’t sweat Novo Nordisk’s head start over Club holding Eli Lilly in the obesity pill…